Bio Green Med Solution (BGMS) EBITDA Margin Growth (3y) (2013 - 2026)
Analysis
Bio Green Med Solution (BGMS) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.39 Bn | 133.54 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.67 Bn | 78.68 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 57.38 Bn | 52.24 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.46 Bn | 44.46 Bn | - | - |
| 6 | BeOne Medicines | 40.47 Bn | 35.37 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.30 Bn | 27.46 Bn | - | -2,649.00 |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 30,461.00 |
| 10 | Bio Green Med Solution | 5.12 Mn | 1.33 Mn | 79,000.00 | 146,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 146,514.00 |
| Dec 31, 2018 | -72,623.00 |
| Dec 31, 2016 | 18,505.00 |
| Sep 30, 2016 | 17,931.00 |
| Jun 30, 2016 | -12,021.00 |
| Mar 31, 2016 | -78,268.00 |
| Dec 31, 2015 | 9.22 Mn |
| Sep 30, 2015 | 879,374.00 |
| Jun 30, 2015 | 1.34 Mn |
| Mar 31, 2015 | 90,002.00 |
| Dec 31, 2014 | -27,975.00 |
| Sep 30, 2014 | 159,443.00 |
| Jun 30, 2014 | 69,411.00 |
| Mar 31, 2014 | 113,384.00 |
| Dec 31, 2013 | -185,708.00 |
| Sep 30, 2013 | 63,906.00 |
| Jun 30, 2013 | 211,223.00 |